Cargando…
Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects
BACKGROUND: Growing evidence has demonstrated that DNA methylation (DNAm) plays an important role in Alzheimer’s disease (AD) and that DNAm differences can be detected in the blood of AD subjects. Most studies have correlated blood DNAm with the clinical diagnosis of AD in living individuals. Howeve...
Autores principales: | Zhang, Wei, Young, Juan I., Gomez, Lissette, Schmidt, Michael A., Lukacsovich, David, Varma, Achintya, Chen, X. Steven, Martin, Eden R., Wang, Lily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088180/ https://www.ncbi.nlm.nih.gov/pubmed/37038196 http://dx.doi.org/10.1186/s13195-023-01216-7 |
Ejemplares similares
-
Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects
por: Zhang, Wei, et al.
Publicado: (2023) -
Distinct sex-specific DNA methylation differences in Alzheimer’s disease
por: C. Silva, Tiago, et al.
Publicado: (2022) -
Critical evaluation of the reliability of DNA methylation probes on the Illumina MethylationEPIC BeadChip microarrays
por: Zhang, Wei, et al.
Publicado: (2023) -
Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer’s disease
por: C. Silva, Tiago, et al.
Publicado: (2022) -
Sex-specific DNA methylation differences in Alzheimer’s disease pathology
por: Zhang, Lanyu, et al.
Publicado: (2021)